American Gene Technologies International Inc. (AGT) is a biotechnology company focused on developing innovative gene and cell therapy solutions for serious human diseases. With a strong commitment to curing HIV, AGT is also advancing treatments in other areas such as liver cancer and rare inherited disorders. Utilizing cutting-edge genetic technologies, the company aims to unlock new possibilities in medicine and improve patient outcomes. AGT’s approach is based on modifying the genetic material of cells to either correct genetic errors, make cells resistant to disease, or equip them with new capabilities to fight diseases. Located in Rockville, Maryland, USA, AGT operates a state-of-the-art facility where scientific research and clinical development unite to push the boundaries of medical science.